◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

HEALTHCARE SERVICES GROUP INC

CIK: 731012 SIC: 8050
$1.84B
Revenue
$59.06M
Net Income
13.03%
Gross Margin
-
Op. Margin
$218.09M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 5 of 16 annual reports available (2010 - 2025)
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
+ Total Revenue $1.84B $1.84B $1.72B $1.67B $1.69B $1.64B
Revenue Growth % 0.0% 7.1% 2.7% -1.1% 2.9% nan%
Cost of Revenue $1.60B $1.60B $1.49B $1.46B $1.50B $1.42B
+ Gross Profit $239.41M $239.41M $228.09M $214.75M $193.84M $226.88M
Gross Margin % 13.0% 13.0% 13.3% 12.8% 11.5% 13.8%
Selling General & Admin $190.87M $190.87M $183.06M $166.77M $140.34M $173.11M
Interest Expense - $1.68M $6.49M $7.81M $2.82M $1.39M
Income Before Tax $67.87M $67.87M $52.94M $53.06M $45.08M $61.82M
Income Tax Expense $8.81M $8.81M $13.47M $14.67M $10.45M $15.96M
+ Net Income $59.06M $59.06M $39.47M $38.39M $34.63M $45.86M
Net Margin % 3.2% 3.2% 2.3% 2.3% 2.0% 2.8%
Basic EPS 0.82 0.82 0.54 0.52 0.47 0.61
Diluted EPS 0.81 0.81 0.53 0.52 0.47 0.61
Basic Shares Outstanding - 72.4M 73.8M 74.3M 74.3M 74.8M
Diluted Shares Outstanding - 73.0M 74.0M 74.3M 74.4M 75.0M
Breakdown FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
Cash & Cash Equivalents $125.19M $56.78M $54.33M $26.28M -
Short-term Investments $42.77M $50.53M $93.13M $95.20M $114.40M
Accounts Receivable $281.30M $330.91M $344.86M - -
Other Current Assets $10.38M $8.39M - - -
Total Current Assets $576.41M $556.65M $571.70M $508.63M $546.38M
Goodwill $79.80M $75.53M $75.53M $75.53M $74.75M
Intangible Assets $6.96M $9.44M $12.13M $15.95M $20.80M
Other Non-current Assets $3.90M $4.09M $1.66M $812.00K -
Total Assets $794.25M $802.77M $790.65M $718.33M $777.53M
Accounts Payable $77.38M $81.15M $83.22M $68.30M $64.42M
Deferred Revenue $8.93M $4.47M - - -
Other Current Liabilities $1.41M $2.99M - - -
Total Current Liabilities $170.38M $192.55M $216.93M $178.62M $191.12M
Other Non-current Liabilities $1.59M $385.00K $2.99M $6.14M $10.46M
Common Stock $768.00K $765.00K $763.00K $762.00K $760.00K
Retained Earnings $283.67M $224.56M $185.01M $154.50M $183.96M
Treasury Stock - - - - $30.16M
Total Stockholders Equity $510.21M $499.93M $456.62M $426.17M $452.68M
Total Liabilities & Equity $794.25M $802.77M $790.65M $718.33M $777.53M
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
Net Income $59.06M $59.06M $39.47M $38.39M $34.63M $45.86M
Depreciation & Amortization $29.54M $16.78M $14.59M $14.34M $15.32M $14.67M
Stock-based Compensation $22.02M $12.01M $9.16M $8.98M $9.21M $8.83M
Deferred Income Tax $2.40M $19.06M $-2.94M $-4.82M $5.05M $3.07M
Change in Inventory $1.18M $48.00K $-1.73M $-2.69M $-4.85M $-5.60M
Operating Cash Flow $228.76M $144.97M $30.80M $43.50M $-8.17M $37.11M
Capital Expenditure $10.66M $5.82M $6.34M $5.41M $5.21M $5.69M
Purchases of Investments $26.76M $18.72M $52.09M - $2.88M $20.34M
Investing Cash Flow $-42.29M $-11.00M $6.05M $-3.29M $2.58M $-22.99M
Stock Issued - - - - $106.00K $92.00K
Stock Repurchased $83.33M $61.59M $5.02M $11.28M - $21.54M
Dividends Paid - - - - $63.37M $62.23M
Financing Cash Flow $-88.56M $-63.33M $-31.05M $-12.15M $-38.93M $-82.65M
Net Change in Cash $97.90M $70.64M $5.80M $28.05M $-44.52M $-68.54M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $464.34M - $1.37B -
Cost of Revenue $367.93M - $1.20B -
Selling General & Admin $50.54M - $144.67M -
Income Before Tax $57.31M - $39.31M -
Income Tax Expense $14.36M - $11.50M -
Net Income $42.95M $-1.79M $27.82M -
Basic EPS 0.59 - 0.38 -
Diluted EPS 0.59 - 0.38 -
Basic Shares Outstanding $72.24M - $73.02M -
Diluted Shares Outstanding $72.97M - $73.50M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $124.39M $56.78M
Short-term Investments $53.07M $50.53M
Accounts Receivable $288.52M $330.91M
Other Current Assets $26.44M $21.80M
Total Current Assets $580.63M $556.65M
Goodwill $80.06M $75.53M
Intangible Assets $7.61M $9.44M
Other Non-current Assets $3.52M $4.09M
Total Assets $804.30M $802.77M
Accounts Payable $81.72M $81.15M
Total Current Liabilities $195.64M $192.55M
Other Non-current Liabilities $1.65M $385.00K
Common Stock $768.00K $765.00K
Retained Earnings $252.42M $224.56M
Total Stockholders Equity $496.00M $499.93M
Total Liabilities & Equity $804.30M $802.77M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $42.95M $-1.79M $27.82M -
Depreciation & Amortization - - $12.91M -
Stock-based Compensation - - $8.88M -
Deferred Income Tax - - $15.94M -
Change in Inventory - - $453.00K -
Operating Cash Flow - - $127.58M -
Capital Expenditure - - $4.44M -
Purchases of Investments - - $13.88M -
Investing Cash Flow - - $-19.57M -
Stock Repurchased - - $41.98M -
Financing Cash Flow - - $-43.73M -
Net Change in Cash - - $64.29M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...